Author | YOP | Study Period | Study Type | TP | NUCP | UCP | NUC Group | UC Group | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OT (min) | P-LOS (day) | UR | UTI | OT (min) | P-LOS (day) | UR | UTI | |||||||
Lai [5] | 2019 | 2014–2017 | Retrospective: cohort study | 2495 | 660 | 1835 | 115 | 4 | 74 (11.2%) | 38 (5.7%) | 120 | 5 | 136 (7.4%) | 153 (8.3%) |
Peng [6] | 2017 | 2014–2015 | Retrospective: case series | 43 | 40 | – | 22 ± 5 | – | 0 (0%) | 0 (0%) | – | – | – | – |
Li [4] | 2017 | 2012–2014 | Retrospective: case series | 34 | 34 | – | 42 ± 10 | 1 ± 1 | 0 (0%) | 0 (0%) | – | – | – | – |
Yang [9] | 2016 | 2015–2016 | Retrospective: cohort study | 148 | 74 | 74 | – | 4.4 ± 1.0 | – | – | – | 6.1 ± 2.0 | – | – |
Qiu [10] | 2016 | 2015–2016 | Retrospective: cohort study | 148 | 74 | 74 | 96.7 ± 30.4 | 4.0 ± 1.1 | 5 (6.7%) | 1 (1.3%) | 107.2 ± 28.4 | 6.2 ± 1.0 | 7 (9.4%) | 3 (4.0%) |
Xu [11] | 2016 | 2014–2015 | Prospective cohort study | 133 | 65 | 68 | – | 5.0 ± 1.6 | 3 (4.6%) | 6 (9.2%) | – | 6.5 ± 3.1 | 7 (10.2%) | 18 (26.4%) |
Qiu [12] | 2015 | 2014.4–2014.12 | Prospective cohort study | 100 | 50 | 50 | – | 5.0 ± 1.5 | 2 (4.0%) | 6 (12.0%) | – | – | 5 (10.0%) | 18 (36.0%) |